Sword Bio
2 known investors
Find your way into Sword Bio
55 people in our graph share verified history with the Sword Bio team — schools, employers, funds. One of them is your warm intro.
Scott Billerunlockedknows Dave Dingott · together at Columbia University (overlapped)
×9knows the team · via Columbia University
×2knows the team · via New York University - Polytechnic School of Engineering
Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
Founders & leadership
DD
Dave DingottinCEO and FounderDave Dingott is CEO and founder of Sword Bio, a bioanalytical contract research organization providing assay development and testing services for pharmaceutical companies. He previously founded Corente, which was sold to Oracle, and served on the board of Cearna, Inc. through its acquisition by Allergan/Abbvie.
Investors · 2
Frequently asked questions
- What does Sword Bio do?
- Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
- Who are Sword Bio's investors?
- Sword Bio's investors include Angel Physicians Fund, Elevate Ventures.